Evidence map›Paper›PMID 19924255›Full record

ArticlePloS one2009

Anthrax lethal toxin induced lysosomal membrane permeabilization and cytosolic cathepsin release is Nlrp1b/Nalp1b-dependent.

Kathleen M Averette, Matthew R Pratt, Yanan Yang, Sara Bassilian, Julian P Whitelegge, Joseph A Loo, Tom W Muir, Kenneth A Bradley

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 67 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Molecular biology of autoinflammatory diseases.Inflammation and regeneration · 2021
    Review
  6. Article
  7. The Lysosome Signaling Platform: Adapting With the Times.Frontiers in cell and developmental biology · 2019
    Review
  8. The Outcome of theJournal of immunology (Baltimore, Md. : 1950) · 2018
    Article
  9. Review
  10. Review
  11. Article
  12. The acidic transformed nano-VOToxicology reports · 2015
    Article
  13. Article
  14. Review
  15. Selective inhibitor of endosomal trafficking pathways exploited by multiple toxins and viruses.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  16. Review
  17. Cytosolic flagellin-induced lysosomal pathway regulates inflammasome-dependent and -independent macrophage responses.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  18. Article
  19. The endolysosomal system in cell death and survival.Cold Spring Harbor perspectives in biology · 2013
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Kathleen M AveretteDepartment of Microbiology, Immunology & Molecular Genetics, University of California Los Angeles, Los Angeles, California, USA.
Matthew R Pratt
Yanan Yang
Sara Bassilian
Julian P Whitelegge
Joseph A Loo
Tom W Muir
Kenneth A Bradley
University of California, Los Angeles · USRockefeller University · US

Funding

Women's CancersP30CA016042 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Samuel Wheeler French · 1985 to 2026
$134.5M
Virology CoreP30AI028697 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ANTON, PETER A · 1991 to 2018
$39.9M
MULTIDISCIPLINARY TRAINING IN MICROBIAL PATHOGENESIST32AI007323 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Peter John Bradley · 1988 to 2026
$8.6M
CHARACTERIZATION OF ANTHRAX TOXIN RECEPTOR INTERACTIONSR01AI057870 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BRADLEY, KENNETH ALAN · 2004 to 2008
$1.7M
Genetics Modifiers of Anthrax Lethal Toxin Induced PathophysiologyR01AI077791 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BRADLEY, KENNETH ALAN · 2009 to 2010
$765k
Genetics Modifiers of Anthrax Lethal Toxin Induced PathophysiologyR56AI077791 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BRADLEY, KENNETH ALAN · 2008 to 2008
$387k
NCI NIH HHS CA16042NCI NIH HHS P30 CA016042NIAID NIH HHS AI057870NIAID NIH HHS AI077791NIAID NIH HHS AI28697NIAID NIH HHS P30 AI028697NIAID NIH HHS R01 AI057870NIAID NIH HHS R01 AI077791NIAID NIH HHS R56 AI077791NIAID NIH HHS T32 AI007323
6 · The paper itself

Abstract

NOD-like receptors (NLRs) are a group of cytoplasmic molecules that recognize microbial invasion or 'danger signals'. Activation of NLRs can induce rapid caspase-1 dependent cell death termed pyroptosis, or a caspase-1 independent cell death termed pyronecrosis. Bacillus anthracis lethal toxin (LT), is recognized by a subset of alleles of the NLR protein Nlrp1b, resulting in pyroptotic cell death of macrophages and dendritic cells. Here we show that LT induces lysosomal membrane permeabilization (LMP). The presentation of LMP requires expression of an LT-responsive allele of Nlrp1b, and is blocked by proteasome inhibitors and heat shock, both of which prevent LT-mediated pyroptosis. Further the lysosomal protease cathepsin B is released into the cell cytosol and cathepsin inhibitors block LT-mediated cell death. These data reveal a role for lysosomal membrane permeabilization in the cellular response to bacterial pathogens and demonstrate a shared requirement for cytosolic relocalization of cathepsins in pyroptosis and pyronecrosis.

Indexed as

Adaptor Proteins, Signal TransducingAllelesAnimalsAntigens, BacterialApoptosis Regulatory ProteinsBacillus anthracisBacterial ToxinsCathepsin BCell LineCytosolLysosomesMacrophagesMiceMice, Inbred C57BLModels, BiologicalNecrosisAdaptor Proteins, Signal Transducinganthrax toxinAntigens, BacterialApoptosis Regulatory ProteinsBacterial ToxinsCathepsin BNLRP1 protein, humanNLR ProteinsProteasome Endopeptidase Complex

Identifiers

PMID19924255
PMCPMC2775945
OpenAlexW2029384396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.